Literature DB >> 30858103

A novel dopamine D1 receptor agonist excites delay-dependent working memory-related neuronal firing in primate dorsolateral prefrontal cortex.

Min Wang1, Dibyadeep Datta2, John Enwright3, Veronica Galvin4, Sheng-Tao Yang4, Constantinos Paspalas4, Rouba Kozak5, David L Gray5, David A Lewis3, Amy F T Arnsten6.   

Abstract

Decades of research have emphasized the importance of dopamine (DA) D1 receptor (D1R) mechanisms to dorsolateral prefrontal cortex (dlPFC) working memory function, and the hope that D1R agonists could be used to treat cognitive disorders. However, existing D1R agonists all have had high affinity for D1R, and engage β-arrestin signaling, and these agonists have suppressed task-related neuronal firing. The current study provides the first physiological characterization of a novel D1R agonist, PF-3628, with low affinity for D1R -more similar to endogenous DA actions- as well as little engagement of β-arrestin signaling. PF-3628 was applied by iontophoresis directly onto dlPFC neurons in aged rhesus monkeys performing a delay-dependent working memory task. Aged monkeys have naturally-occurring loss of DA, and naturally-occurring reductions in dlPFC neuronal firing and working memory performance. We found the first evidence of excitatory actions of a D1R agonist on dlPFC task-related firing, and this PF-3628 beneficial response was blocked by co-application of a D1R antagonist. These D1R actions likely occur on pyramidal cells, based on previous immunoelectron microscopic studies showing expression of D1R on layer III spines, and current microarray experiments showing that D1R are four times more prevalent in pyramidal cells than in parvalbumin-containing interneurons laser-captured from layer III of the human dlPFC. These results encourage the translation of D1R mechanisms from monkey to human, with the hope PF-3628 and related, novel D1R agonists will be more appropriate for enhancing dlPFC cognitive functions in patients with mental disorders.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Aging; Cognition; GABA interneuron; Pyramidal cell; Schizophrenia

Mesh:

Substances:

Year:  2019        PMID: 30858103      PMCID: PMC6475613          DOI: 10.1016/j.neuropharm.2019.03.001

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  15 in total

1.  A Dopamine D1 Agonist Versus Methylphenidate in Modulating Prefrontal Cortical Working Memory.

Authors:  Yang Yang; Mechelle M Lewis; Lan Kong; Richard B Mailman
Journal:  J Pharmacol Exp Ther       Date:  2022-06-05       Impact factor: 4.402

2.  Dose-Dependent Regulation on Prefrontal Neuronal Working Memory by Dopamine D1 Agonists: Evidence of Receptor Functional Selectivity-Related Mechanisms.

Authors:  Yang Yang; Susan D Kocher; Mechelle M Lewis; Richard B Mailman
Journal:  Front Neurosci       Date:  2022-06-16       Impact factor: 5.152

3.  Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation.

Authors:  Rouba Kozak; Tamás Kiss; Keith Dlugolenski; David E Johnson; Roxanne R Gorczyca; Kyle Kuszpit; Brian D Harvey; Polina Stolyar; Stacey J Sukoff Rizzo; William E Hoffmann; Dmitri Volfson; Mihaly Hajós; Jennifer E Davoren; Amanda L Abbott; Graham V Williams; Stacy A Castner; David L Gray
Journal:  Front Pharmacol       Date:  2020-07-07       Impact factor: 5.810

4.  Differential Effects of Pergolide and Bromocriptine on Working Memory Performance and Brain Activation after Mild Traumatic Brain Injury.

Authors:  Laura A Flashman; Brenna C McDonald; James C Ford; Rachel M Kenny; Katharine D Andrews; Andrew J Saykin; Thomas W McAllister
Journal:  J Neurotrauma       Date:  2020-08-10       Impact factor: 5.269

5.  Ketamine-Induced Alteration of Working Memory Utility during Oculomotor Foraging Task in Monkeys.

Authors:  Ryo Sawagashira; Masaki Tanaka
Journal:  eNeuro       Date:  2021-04-06

6.  Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for Schizophrenia.

Authors:  Anissa Abi-Dargham; Jonathan A Javitch; Mark Slifstein; Alan Anticevic; Monica E Calkins; Youngsun T Cho; Clara Fonteneau; Roberto Gil; Ragy Girgis; Raquel E Gur; Ruben C Gur; Jack Grinband; Joshua Kantrowitz; Christian Kohler; John Krystal; John Murray; Mohini Ranganathan; Nicole Santamauro; Jared Van Snellenberg; Zailyn Tamayo; Daniel Wolf; David Gray; Jeffrey Lieberman
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 7.348

Review 7.  Associations Among Monoamine Neurotransmitter Pathways, Personality Traits, and Major Depressive Disorder.

Authors:  Xiaojun Shao; Gang Zhu
Journal:  Front Psychiatry       Date:  2020-05-13       Impact factor: 4.157

8.  Network Models Predict That Pyramidal Neuron Hyperexcitability and Synapse Loss in the dlPFC Lead to Age-Related Spatial Working Memory Impairment in Rhesus Monkeys.

Authors:  Sara Ibañez; Jennifer I Luebke; Wayne Chang; Danel Draguljić; Christina M Weaver
Journal:  Front Comput Neurosci       Date:  2020-01-17       Impact factor: 2.380

Review 9.  Mechanisms underlying dorsolateral prefrontal cortex contributions to cognitive dysfunction in schizophrenia.

Authors:  Jason Smucny; Samuel J Dienel; David A Lewis; Cameron S Carter
Journal:  Neuropsychopharmacology       Date:  2021-07-20       Impact factor: 7.853

Review 10.  The Role of Chinese Herbal Therapy in Methamphetamine Abuse and its Induced Psychiatric Symptoms.

Authors:  Lin Chen; Qin Ru; Qi Xiong; Mei Zhou; Kai Yue; Yuxiang Wu
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.